AKASA
PrivateLast Round
Early Funding
Jun 18, 2024
Est. Valuation
$94.43M
Total Funding Raised
$325M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AKASA is a healthcare technology company that provides generative AI solutions to streamline revenue cycle management for health systems.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Healthcare Analytics, Workflow Automation, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AKASA Comparables
Compare AKASA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adonis | 87% | |
| Janus Health | 86% | |
| Arintra | 85% | |
AKASA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 18, 2024 | ||||
| Series B | Mar 23, 2021 | ||||
| Series A | Jun 10, 2020 | ||||
| Seed | Dec 20, 2018 |
Key People
Founding team and executive leadership
AKASA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Early Funding, Series C, Series B, Seed, Series A |
| Bond Capital | Series B |
| Costanoa Ventures | Early Funding, Seed, Series C, Series B, Series A |
| Coatue Management | Series C |
| BOND | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 22, 2026
CEO ranked among Top 50 Healthcare Technology CEOs.
- Mar 22, 2026
Certified for 6 consecutive years.
AKASA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AKASA's valuation, stock price, and market status.